Print
Email
Savient Pharmaceuticals Inc. has a market cap of $165.1 million; its shares were traded at around $2.31 with and P/S ratio of 41. Savient Pharmaceuticals Inc. had an annual average earning growth of 79.7% over the past 5 years.
This is the annual revenues and earnings per share of SVNT over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of SVNT.
CEO Recent Trades:
- CEO & President John Johnson bought 5,000 shares of SVNT stock on 11/21/2011 at the average price of 2.3. John Johnson owns at least 270,000 shares after this. The price of the stock has increased by 0.43% since.
- CEO & President John Johnson bought 11,000 shares of SVNT stock on 11/18/2011 at the average price of 2.29. John Johnson owns at least 269,000 shares after this. The price of the stock has increased by 0.87% since.
- CEO & President John Johnson bought 28,000 shares of SVNT stock on 09/16/2011 at the average price of 4.09. John Johnson owns at least 258,000 shares after this. The price of the stock has decreased by 43.52% since.
CFO Recent Trades:
- EVP, CFO Kenneth J Zuerblis bought 2,000 shares of SVNT stock on 11/18/2011 at the average price of 2.35. Kenneth J Zuerblis owns at least 7,000 shares after this. The price of the stock has decreased by 1.7% since.
- EVP, CFO Kenneth J Zuerblis bought 5,000 shares of SVNT stock on 09/15/2011 at the average price of 4.03. Kenneth J Zuerblis owns at least 5,000 shares after this. The price of the stock has decreased by 42.68% since.
This is the insider trade history vs. stock price of SVNT. For the complete insider trading history of SVNT, click here.
Directors and Officers Recent Trades:
- SVP, North American Commerical Louis Ferrari bought 4,000 shares of SVNT stock on 11/21/2011 at the average price of 2.29. Louis Ferrari owns at least 44,000 shares after this. The price of the stock has increased by 0.87% since.
- EVP Biopharmaceutical Operatio Richard Crowley bought 3,000 shares of SVNT stock on 11/21/2011 at the average price of 2.53. Richard Crowley owns at least 103,000 shares after this. The price of the stock has decreased by 8.7% since.
- SVP, Chief Medical Officer Kenneth Bahrt bought 5,000 shares of SVNT stock on 11/16/2011 at the average price of 2.59. Kenneth Bahrt owns at least 58,000 shares after this. The price of the stock has decreased by 10.81% since.
- SVP, General Counsel Philip K Yachmetz bought 7,000 shares of SVNT stock on 09/16/2011 at the average price of 4.13. Philip K Yachmetz owns at least 189,024 shares after this. The price of the stock has decreased by 44.07% since.
- Director Alan L Heller bought 7,500 shares of SVNT stock on 09/15/2011 at the average price of 3.99. Alan L Heller owns at least 40,179 shares after this. The price of the stock has decreased by 42.11% since.
For the complete insider trading history of SVNT, click here.
Subscribe RSS
